Request Deal Involvement
AEON Biopharma went public via a SPAC merger with Priveterra Acquisition in a $475m deal.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Latham & Watkins
pr advisors
LifeSci Partners
financial advisors
Canaccord Genuity
financial advisors
HC Wainwright
financial advisors
Cohen & Company Capital Markets
legal advisors
Davis Polk & Wardwell
financial advisors
ROTH Capital Partners
or
Principals
target
AEON BIOPHARMA
bidder
PRIVETERRA ACQUISITION CORP
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite